Flagship Harbor Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Flagship Harbor Advisors’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-270	Closed	-$13K	–	2234
2020 Q1	$13K	Hold	270	–	–	﹤0.01%	1160
2019 Q4	$13K	Hold	270	–	–	﹤0.01%	1265
2019 Q3	$6K	Hold	270	–	–	﹤0.01%	1469
2019 Q2	$8K	Buy	+270	New	+$6.18K	﹤0.01%	1386

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Flagship Harbor Advisors's RARX Position: Q2 2020 in Review

Flagship Harbor Advisors sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 270 shares — an estimated $13K sold.

Flagship Harbor Advisors first reported a position in RARX in Q2 2019 and held it in 4 quarters. The position peaked at $13K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Flagship Harbor Advisors reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Flagship Harbor Advisors sold 270 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $13K.
Flagship Harbor Advisors first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
Flagship Harbor Advisors's Ra Pharmaceuticals, Inc. Common Stock position peaked at $13K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Flagship Harbor Advisors's 13F filing for Q2 2020, filed 31 Jul 2020.